About Contact Us Careers
Sign In

Biliary Interventional Radiology Devices Market - Top Companies and Manufacturers

  • Report ID: 3162
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Biliary Interventional Radiology Devices Landscape

    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • GE Healthcare (General Electric Company)
    •  Siemens Healthcare GmBH
    •  Royal Philips
    •  Toshiba Medical Systems Corporation
    •  Hitachi Medical Corporation
    •  Carestream Health, Inc.
    •  Esaote S.p.A
    •  Hologic, Inc.
    •  Fujifilm Corporation
Browse Key Market Insights with Data Illustration:

In the News

  • April 2021: Royal Philips a global leader in health technology, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, announced collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
  • November 2020: Abbott announced the launch of the IonicRF™ Generator. It is recently cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
  • August 2019: NinePoint Medical, Inc., announced that it has received U.S. Food and Drug Administration clearance to market the NvisionVLE Imaging System for use in the pancreas and bile duct.

Author Credits:  Radhika Pawar


  • Report ID: 3162
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising occurrence of cancer, chronic diseases and increasing elderly population are the key factors driving market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

Costly therapies and lack of awareness about cancer therapies in lower economic regions are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about cancer.

The major players dominating the are GE Healthcare (General Electric Company), Siemens Healthcare GmBH, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, Inc., Esaote S.p.A, Hologic, Inc., Fujifilm Corporation, Samsung Medison among others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample